Cargando…

Efficacy of Trabectedin in Patients with Advanced Translocation‐Related Sarcomas: Pooled Analysis of Two Phase II Studies

BACKGROUND. Trabectedin is reported as effective, especially against translocation‐related sarcomas (TRSs) after failure of or intolerance to standard chemotherapy. We conducted two phase II studies of TRS, confirming high efficacy of 1.2 mg/m(2) trabectedin. The updated data of 66 patients in these...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takahashi, Mitsuru, Takahashi, Shunji, Araki, Nobuhito, Sugiura, Hideshi, Ueda, Takafumi, Yonemoto, Tsukasa, Morioka, Hideo, Hiraga, Hiroaki, Hiruma, Toru, Kunisada, Toshiyuki, Matsumine, Akihiko, Shimura, Masashi, Kawai, Akira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AlphaMed Press 2017
Materias:	Sarcomas
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5553952/ https://www.ncbi.nlm.nih.gov/pubmed/28526720 http://dx.doi.org/10.1634/theoncologist.2016-0064

Ejemplares similares

Time lapse analysis of tumor response in patients with soft tissue sarcoma treated with trabectedin: A pooled analysis of two phase II clinical trials
por: Endo, Makoto, et al.
Publicado: (2020)

Results of sub-analysis of a phase 2 study on trabectedin treatment for extraskeletal myxoid chondrosarcoma and mesenchymal chondrosarcoma
por: Morioka, Hideo, et al.
Publicado: (2016)

Systemic Therapy for Soft Tissue Sarcoma: Proposals for the Optimal Use of Pazopanib, Trabectedin, and Eribulin
por: Kawai, Akira, et al.
Publicado: (2017)

The clinical outcome of pazopanib treatment in Japanese patients with relapsed soft tissue sarcoma: A Japanese Musculoskeletal Oncology Group (JMOG) study
por: Nakamura, Tomoki, et al.
Publicado: (2016)

Prognostic Value of Relevant Clinicopathologic Variables in Epithelioid Sarcoma: A Multi-Institutional Retrospective Study of 44 Patients
por: Asano, Naofumi, et al.
Publicado: (2015)

A randomized, double-blind, placebo-controlled, Phase III study of pazopanib in patients with soft tissue sarcoma: results from the Japanese subgroup
por: Kawai, Akira, et al.
Publicado: (2016)

Pexidartinib Long‐Term Hepatic Safety Profile in Patients with Tenosynovial Giant Cell Tumors
por: Lewis, James H., et al.
Publicado: (2020)

Phase 2 study of eribulin in patients with previously treated advanced or metastatic soft tissue sarcoma(†)
por: Kawai, Akira, et al.
Publicado: (2017)

Early symptoms of bone and soft tissue sarcomas: could they be diagnosed earlier?
por: George, A, et al.
Publicado: (2012)

Feasibility and Efficacy of Microwave Ablation Combined with Iodine‐125 Seed Implantation in Local Control of Recurrent Retroperitoneal Liposarcomas: Initial Clinical Experience
por: Lu, Mingjian, et al.
Publicado: (2017)

Clinical Activity of Pazopanib in Patients with Advanced Desmoplastic Small Round Cell Tumor
por: Menegaz, Brian A., et al.
Publicado: (2017)

Saving the hand: Role of multimodality therapy for Ewing's sarcoma family tumor of the palm
por: Joseph, Sanjay A., et al.
Publicado: (2018)

Defining Tumor Rupture in Gastrointestinal Stromal Tumor
por: Nishida, Toshirou, et al.
Publicado: (2019)

MRI Radiomic Features Are Independently Associated With Overall Survival in Soft Tissue Sarcoma
por: Spraker, Matthew B., et al.
Publicado: (2019)

Sarcoma European and Latin American Network (SELNET) Recommendations on Prioritization in Sarcoma Care During the COVID‐19 Pandemic
por: Martin‐Broto, Javier, et al.
Publicado: (2020)

Single‐Center Experience with Ifosfamide Monotherapy as Second‐Line Treatment of Recurrent/Metastatic Osteosarcoma
por: Verschoor, Arie Jan, et al.
Publicado: (2019)

The Landmark Series: Systemic Therapy for Resectable Gastrointestinal Stromal Tumors
por: Keung, Emily Z., et al.
Publicado: (2020)

Role of Resection Following Focal Progression with Standard Doses of Imatinib in Patients with Advanced Gastrointestinal Stromal Tumors: Results of Propensity Score Analyses
por: Cho, Hyungwoo, et al.
Publicado: (2019)

Primary Angiosarcoma—A Rare Cause of Right Ventricular Outflow Tract Obstruction: Case Report and Literature Review
por: Omair, Mohammad, et al.
Publicado: (2019)

Atrial Thrombus Mimicking Ewing's Sarcoma
por: Hon, Matthew, et al.
Publicado: (2019)

Neoadjuvant Chemoradiation Compared With Neoadjuvant Radiation Alone in the Management of High-Grade Soft Tissue Extremity Sarcomas
por: Hazell, Sarah Z., et al.
Publicado: (2019)

First-In-Human Phase 1 Study of a Nonwoven Fabric Bioabsorbable Spacer for Particle Therapy: Space-Making Particle Therapy (SMPT)
por: Sasaki, Ryohei, et al.
Publicado: (2019)

Functional Outcome Measurement in Patients with Lower-Extremity Soft Tissue Sarcoma: A Systematic Literature Review
por: Kask, Gilber, et al.
Publicado: (2019)

Integrating Anatomical, Molecular and Clinical Risk Factors in Gastrointestinal Stromal Tumor of the Stomach
por: Hølmebakk, Toto, et al.
Publicado: (2021)

Soft Tissue Sarcoma of Lower Extremity: Functional Outcome and Quality of Life
por: Kask, Gilber, et al.
Publicado: (2021)

Clinical Benefit of Ripretinib Dose Escalation After Disease Progression in Advanced Gastrointestinal Stromal Tumor: An Analysis of the INVICTUS Study
por: Zalcberg, John R., et al.
Publicado: (2021)

Percutaneous Cementoplasty for the Pelvis in Bone Metastasis: 12-Year Experience
por: Park, Jong Woong, et al.
Publicado: (2021)

Management of Soft Tissue Sarcomas in Extremities: Variation in Treatment Recommendations and Surveillance According to Specialty and Continent
por: Acem, Ibtissam, et al.
Publicado: (2021)

Late Local Recurrence and Metastasis in Soft Tissue Sarcoma of the Extremities and Trunk Wall: Better Outcome After Treatment of Late Events Compared with Early
por: von Konow, Arvid, et al.
Publicado: (2021)

Frailty in Very Elderly Patients is Not Associated with Adverse Surgical or Oncological Outcomes in Extremity Surgery for Soft Tissue Sarcoma
por: Sivarajah, Gausihi, et al.
Publicado: (2022)

Histiocytic and Dendritic Cell Sarcomas of Hematopoietic Origin Share Targetable Genomic Alterations Distinct from Follicular Dendritic Cell Sarcoma
por: Massoth, Lucas R., et al.
Publicado: (2021)

Anlotinib, Vincristine, and Irinotecan for Advanced Ewing Sarcoma After Failure of Standard Multimodal Therapy: A Two‐Cohort, Phase Ib/II Trial
por: Xu, Jie, et al.
Publicado: (2021)

Immune-Desert Tumor Microenvironment in Thoracic SMARCA4-Deficient Undifferentiated Tumors with Limited Efficacy of Immune Checkpoint Inhibitors
por: Gantzer, Justine, et al.
Publicado: (2022)

Phase II Study of Cabozantinib in Patients With Bone Metastasis
por: Choy, Edwin, et al.
Publicado: (2022)

Giant Cell Tumor of Bone: Effect of Longer Dosing Intervals of Denosumab on Tumor Control and Bone-related Complications
por: Jiang, Cindy Y, et al.
Publicado: (2022)

Functional Outcome Following Proximal Tibial Osteosarcoma Resection and Reconstruction by Modular Endoprosthesis
por: Ebeid, Walid Atef, et al.
Publicado: (2022)

Unplanned Excision of Soft Tissue Sarcomas of the Extremities in a Low-to-Middle-Income Country
por: Wang, Edward H. M., et al.
Publicado: (2023)

Patterns of Metastatic Recurrence of Genetically Confirmed Myxoid Liposarcoma
por: Homsy, Pauliina, et al.
Publicado: (2023)

Efficacy and Safety of Adjuvant Radiotherapy in Re-excised Soft-tissue Sarcoma After Unplanned Resection
por: Allignet, Benoît, et al.
Publicado: (2023)

Functional and Oncological Outcome of Patients with Distal Femoral Osteosarcoma Managed by Limb Salvage Using Modular Endoprosthesis
por: Sadek, Wael Mohamed Safwat, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4p55jek8buk2td6jdo768l1d8j